User menu

Effect of Obesity on Growth-related Oncogene Factor-alpha, Thrombopoietin, and Tissue Inhibitor Metalloproteinase-1 Serum Levels.

Bibliographic reference Maury, Eléonore ; Brichard, Sonia ; Pataky, Zoltan ; Carpentier, Anne ; Golay, Alain ; et. al. Effect of Obesity on Growth-related Oncogene Factor-alpha, Thrombopoietin, and Tissue Inhibitor Metalloproteinase-1 Serum Levels.. In: Obesity (Silver Spring, Md.), Vol. 18, no. 8, p. 1503-1509 (2010)
Permanent URL http://hdl.handle.net/2078.1/28915
  1. Matsuzawa Yuji, Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease, 10.1038/ncpcardio0380
  2. Lyon Christopher J., Law Ronald E., Hsueh Willa A., Minireview: Adiposity, Inflammation, and Atherogenesis, 10.1210/en.2003-0285
  3. Guerre-Millo M, Adipose tissue and adipokines: for better or worse, 10.1016/s1262-3636(07)70084-8
  4. Skurk Thomas, Alberti-Huber Catherine, Herder Christian, Hauner Hans, Relationship between Adipocyte Size and Adipokine Expression and Secretion, 10.1210/jc.2006-1055
  5. Jernas M., Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression, 10.1096/fj.05-5678fje
  6. Herder C., Baumert J., Thorand B., Koenig W., de Jager W., Meisinger C., Illig T., Martin S., Kolb H., Chemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg study, 1984–2002, 10.1007/s00125-006-0190-y
  7. Maury E., Ehala-Aleksejev K., Guiot Y., Detry R., Vandenhooft A., Brichard S. M., Adipokines oversecreted by omental adipose tissue in human obesity, 10.1152/ajpendo.00127.2007
  8. Diabetes Care, 32, S13 (2009)
  9. Segal KR, Am J Clin Nutr, 47, 7 (1988)
  10. Simonson DC, Am J Physiol, 258, E399 (1990)
  11. Ferrannini Eleuterio, The theoretical bases of indirect calorimetry: A review, 10.1016/0026-0495(88)90110-2
  12. Isaksson B, Am J Clin Nutr, 33, 4 (1980)
  13. DeFronzo RA, Am J Physiol, 237, E214 (1979)
  14. Miller A. P., Estrogen Modulates Inflammatory Mediator Expression and Neutrophil Chemotaxis in Injured Arteries, 10.1161/01.cir.0000142050.19488.c7
  15. Kanda Yuki, Koike Dr. Koji, Sakamoto Yoshiki, Osako Yasuko, Masuhara Kanji, Watanabe Kazuyoshi, Tsurufuji Susumu, Hirota Kenji, Miyake Akira, GRO-alpha in Human Serum: Differences Related to Age and Sex, 10.1111/j.1600-0897.1997.tb00273.x
  16. Breland U. M., Halvorsen B., Hol J., Oie E., Paulsson-Berne G., Yndestad A., Smith C., Otterdal K., Hedin U., Waehre T., Sandberg W. J., Froland S. S., Haraldsen G., Gullestad L., Damas J. K., Hansson G. K., Aukrust P., A Potential Role of the CXC Chemokine GRO  in Atherosclerosis and Plaque Destabilization: Downregulatory Effects of Statins, 10.1161/atvbaha.108.162305
  17. HALINSKI RONALD S., FELDT LEONARD S., THE SELECTION OF VARIABLES IN MULTIPLE REGRESSION ANALYSIS, 10.1111/j.1745-3984.1970.tb00709.x
  18. Alberti K George MM, Zimmet Paul, Shaw Jonathan, The metabolic syndrome—a new worldwide definition, 10.1016/s0140-6736(05)67402-8
  19. Lane B. R., Liu J., Bock P. J., Schols D., Coffey M. J., Strieter R. M., Polverini P. J., Markovitz D. M., Interleukin-8 and Growth-Regulated Oncogene Alpha Mediate Angiogenesis in Kaposi's Sarcoma, 10.1128/jvi.76.22.11570-11583.2002
  20. Lupia Enrico, Bosco Ornella, Bergerone Serena, Dondi Anna Erna, Goffi Alberto, Oliaro Elena, Cordero Marco, Del Sorbo Lorenzo, Trevi Giampaolo, Montrucchio Giuseppe, Thrombopoietin Contributes to Enhanced Platelet Activation in Patients With Unstable Angina, 10.1016/j.jacc.2006.04.106
  21. Kralisch S., Bluher M., Tonjes A., Lossner U., Paschke R., Stumvoll M., Fasshauer M., Tissue inhibitor of metalloproteinase-1 predicts adiposity in humans, 10.1530/eje.1.02328
  22. Kosmala W, Plaksej R, Przewlocka-Kosmala M, Kuliczkowska-Plaksej J, Bednarek-Tupikowska G, Mazurek W, Matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in premenopausal obese women: relationship to cardiac function, 10.1038/sj.ijo.0803794
  23. Lumeng Carey N., Bodzin Jennifer L., Saltiel Alan R., Obesity induces a phenotypic switch in adipose tissue macrophage polarization, 10.1172/jci29881
  24. Lumeng C. N., DeYoung S. M., Bodzin J. L., Saltiel A. R., Increased Inflammatory Properties of Adipose Tissue Macrophages Recruited During Diet-Induced Obesity, 10.2337/db06-1076
  25. Maury E., Brichard S.M., Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome, 10.1016/j.mce.2009.07.031
  26. Klein S., Allison D. B., Heymsfield S. B., Kelley D. E., Leibel R. L., Nonas C., Kahn R., Waist Circumference and Cardiometabolic Risk: A Consensus Statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; the American Society for Nutrition; and the American Diabetes Association, 10.2337/dc07-9921
  27. Maury Eléonore, Noël Laurence, Detry Roger, Brichard Sonia M., In VitroHyperresponsiveness to Tumor Necrosis Factor-α Contributes to Adipokine Dysregulation in Omental Adipocytes of Obese Subjects, 10.1210/jc.2008-2196
  28. Alexander Caroline M., Selvarajan Sushma, Mudgett John, Werb Zena, Stromelysin-1 Regulates Adipogenesis during Mammary Gland Involution, 10.1083/jcb.152.4.693
  29. Lijnen H. R., Nutritionally Induced Obesity Is Attenuated in Transgenic Mice Overexpressing Plasminogen Activator Inhibitor-1, 10.1161/01.atv.0000044457.60665.dd
  30. Dietze-Schroeder D., Sell H., Uhlig M., Koenen M., Eckel J., Autocrine Action of Adiponectin on Human Fat Cells Prevents the Release of Insulin Resistance-Inducing Factors, 10.2337/diabetes.54.7.2003
  31. Undas A., Wiek I., Stepien E., Zmudka K., Tracz W., Hyperglycemia Is Associated With Enhanced Thrombin Formation, Platelet Activation, and Fibrin Clot Resistance to Lysis in Patients With Acute Coronary Syndrome, 10.2337/dc08-0282
  32. ŞENARAN HANDAN, Ileri Mehmet, AltinbaŞ Ahmet, KoŞar Ali, Yetkin Ertan, ÖZTÜRK Mustafa, Karaaslan YaŞar, Kirazli Şerafettin, Thrombopoietin and mean platelet volume in coronary artery disease, 10.1002/clc.4960240511
  33. Zureik Mahmoud, Beaudeux Jean-Louis, Courbon Dominique, Bénétos Athanase, Ducimetière Pierre, Serum tissue inhibitors of metalloproteinases 1 (TIMP-1) and carotid atherosclerosis and aortic arterial stiffness : , 10.1097/01.hjh.0000191245.68443.24
  34. Frezza E E, Influence of obesity on the risk of developing colon cancer, 10.1136/gut.2005.073163
  35. Vona-Davis L., Rose D. P, Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression, 10.1677/erc-06-0068
  36. Schäffler Andreas, Schölmerich Jürgen, Buechler Christa, Mechanisms of Disease: adipokines and breast cancer—endocrine and paracrine mechanisms that connect adiposity and breast cancer, 10.1038/ncpendmet0456
  37. Hsing AW, Am J Clin Nutr, 86, s843 (2007)
  38. Haghnegahdar H, J Leukoc Biol, 67, 53 (2000)
  39. Hornebeck William, Lambert Elise, Petitfrère Emmanuelle, Bernard Philippe, Beneficial and detrimental influences of tissue inhibitor of metalloproteinase-1 (TIMP-1) in tumor progression, 10.1016/j.biochi.2004.09.022
  40. Wen Y., Giardina S. F., Hamming D., Greenman J., Zachariah E., Bacolod M. D., Liu H., Shia J., Amenta P. S., Barany F., Paty P., Gerald W., Notterman D., GRO  Is Highly Expressed in Adenocarcinoma of the Colon and Down-Regulates Fibulin-1, 10.1158/1078-0432.ccr-06-0736
  41. Stetler-Stevenson W. G., Tissue Inhibitors of Metalloproteinases in Cell Signaling: Metalloproteinase-Independent Biological Activities, 10.1126/scisignal.127re6